Further, BRCA1, BRCA2 and PALB2 mutant pancreatic cancer frequently shows signature 3 [42,143], and the presence of signature 3 is predictive of response to platinum chemotherapy in patients with advanced pancreatic cancer [9]. The gene discussed is PALB2; the disease is familial pancreatic carcinoma.